Prior authorization: Patient involvement and time burden in cancer treatment.
Year: 2025
Type: conference-abstract
Source: JCO Oncology Practice
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
Funders: Pfizer, Regeneron Pharmaceuticals, Exelixis
OpenAlex ID: W4414893121
